SCP27: WIPO patent committee agrees to future work on patent oppositions, exceptions and limitations, and patents and health

On Friday afternoon, 15 December 2017, the 27th session of the WIPO Standing Committee on the Law of Patents (SCP) agreed to a future program of work that included the following topics: 1) Exceptions and Limitations to Patent Rights, 2) Quality of Patents, including Opposition Systems, 3) Patents and Health, Confidentiality of Communications between Clients …

thiru's Blog Send by email Send by email Add new comment Read more

KEI reaction to 11th WTO Ministerial Conference – Joint Statement on E-Commerce

On December 13, 2017, a joint statement on e-commerce was endorsed by Ministers representing 70 WTO members at the 11th WTO Ministerial Conference in Buenos Aires, Argentina (see below). KEI’s statement on the WTO e-commerce agenda is as follows: “There is no question about the importance of e-commerce and digital trade. Less clear is why …

Claire Cassedy's Blog Send by email Send by email Add new comment Read more

SCP27: South Africa urges WIPO to invite UNHLP Co-Chairs to present their findings

On Tuesday, 12 December 2017, the South African delegation to the WIPO Standing Committee on the Law of Patents (SCP) delivered the following statement on patents and health. South Africa reiterated its strong support for the Report of the UN High-Level Panel on Access to Medicines and exhorted the Committee to invite the Co-Chairs of …

thiru's Blog Send by email Send by email Add new comment Read more

SCP27: KEI statement on pressures faced by Brazil and Colombia in using TRIPS flexibilities

On 12 December 2017, KEI delivered the following intervention to WIPO on pressures faced by Brazil and Colombia in using TRIPS flexibilities. 12 December 2017 SCP 27 Thank you Chair. We welcome the opportunity to provide inputs on the constraints faced by developing countries and LDCs in making full use of patent flexibilities in promoting …

thiru's Blog Send by email Send by email Add new comment Read more

SCP27: KEI statement on patents and health

On Tuesday, 12 December 2017, Knowledge Ecology International delivered the following intervention at the 27th session of the WIPO Standing Committee of the Law of Patents during discussions of a work program on patents and health. Knowledge Ecology International reiterates our strong support for the African proposal contained in document SCP/24/4 on a work program …

thiru's Blog Send by email Send by email Add new comment Read more

WIPO SCP27: KEI statement on exceptions and limitations to patent rights

On Monday, 11 December 2017, KEI delivered the following statement in response to WIPO’s publication of a  Draft Reference Document on Exception Regarding Acts for Obtaining Regulatory Approval from Authorities. KEI commends the work of the WIPO secretariat in preparing Draft Reference Document (SCP27/3) on Exception Regarding Acts for Obtaining Regulatory Approval from Authorities. The …

thiru's Blog Send by email Send by email Add new comment Read more

Asia Pacific Group asks WIPO to initiate exploratory discussions on the Report of the UN High Level Panel on Access to Medicines

On Monday, 11 December 2017, Indonesia, on behalf of the Asia Pacific Group, delivered the following opening statement at the 27th session of the WIPO Standing Committee on the Law of Patents (SCP). The Asia Pacific Group issued a clarion call exhorting WIPO to initiate exploratory discussions on the Report of the UN High-Level Panel …

thiru's Blog Send by email Send by email Add new comment Read more

KEI comments to WIPO SCP on constraints faced by countries in making full use of TRIPS flexibilities

On 8 December 2017, Knowledge Ecology International (KEI) submitted the following paper on “constraints faced by developing countries and least developed countries (LDCs) in making full use of patent flexibilities and their impacts” on access to medicines pursuant to the decision of the World Intellectual Property Organization’s (WIPO) Standing Committee on the Law of Patents (SCP) …

thiru's Blog Send by email Send by email Add new comment Read more

Background FAQ on Chile compulsory licensing request for HCV and prostate cancer treatments

For more information, contact: (U.S.) Andrew Goldman, KEI: andrew.goldman@keionline.org or +1 (202) 332-2670 (Chile) Luis Villaroel, Innovarte: info@innovarte.cl +56 9 9827 9673 Chile FAQ What is happening in Chile with regard to HCV medicines and Xtandi, for prostate cancer? In March of 2017, patients, members of the Chilean congress, and NGOs submitted a petition to …

Andrew Goldman's Blog Send by email Send by email Add new comment Read more

NGOs and patient groups call upon Chilean President, Minister of Health to issue a compulsory license for cancer and Hepatitis drugs

FOR IMMEDIATE RELEASE Contact: Kim Treanor kim.treanor@keionline.org; 202-332-2670 Patient groups, civil society and concerned individuals from Chile and around the world call upon President Michelle Bachelet Jeria and Dr. Carmen Castillo Taucher, Minister of Health, to issue a compulsory license for patents on HCV and prostate cancer medicines. A letter signed by these groups and …

Kim Treanor's Blog Send by email Send by email Add new comment Read more 2 attachment